It is well known that NF-κB and STAT3 signaling plays an essential role in cell growth, differentiation, apoptosis, and previous study revealed that SHMT2 is a new player in STAT3 signaling in cancer (Marrocco et al., 2019). This evidence concerns the gene STAT3 and cancer.